Scientists discovered that low doses of THC as part of a longer-term treatment plan have an anti-aging effect and may reverse ...

Pacylex was recognized as BioAlberta's 2024 Company of the Year. The award acknowledges a company that has shown significant achievement within the marketplace and Alberta's business community through ...

mTOR and tyrosine kinase inhibitors may play an increasing role in the management of well-differentiated neuroendocrine tumors in the future. Peptide receptor radiotherapy is a new treatment ...

The company’s lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway ... endothelial growth factor receptor 3. The company was formerly ...

Compared to placebo (dummy medicine), tolvaptan (a class of medicine known as vasopressin 2 receptor antagonists) probably preserves kidney function and slows the increase in total kidney volume; ...

Odyssey Therapeutics announced the formation of its Scientific Advisory Board, which includes experts in immunology and therapeutic development.

In mammals, autophagosome formation, a central event in autophagy, is initiated by the ULK complex comprising ULK1/2, FIP200, ATG13, and ATG101. However, the structural basis and mechanism of the ULK ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this ...

Researchers used artificial intelligence (AI) to study how infants transition from random movements to purposeful actions. By tracking infant movements in a baby-mobile experiment, AI models like ...